| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/10/2003 | US20030068698 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 04/10/2003 | US20030068697 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 04/10/2003 | US20030068696 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/10/2003 | US20030068695 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/10/2003 | US20030068694 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/10/2003 | US20030068693 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 04/10/2003 | US20030068692 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/10/2003 | US20030068691 Peptide for use in the treatment and diagnosis of nervous system, epilepsy and stroke |
| 04/10/2003 | US20030068690 Process for the in vitro culture of different stages of tissular parasites |
| 04/10/2003 | US20030068689 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/10/2003 | US20030068688 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/10/2003 | US20030068687 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/10/2003 | US20030068686 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 04/10/2003 | US20030068685 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 04/10/2003 | US20030068684 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/10/2003 | US20030068683 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/10/2003 | US20030068682 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 04/10/2003 | US20030068681 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/10/2003 | US20030068680 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of tumors |
| 04/10/2003 | US20030068679 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of tumors |
| 04/10/2003 | US20030068678 WISP polypeptides and nucleic acids encoding same |
| 04/10/2003 | US20030068674 Method of producing a biosensor protein capable of regulating a fluorescence property of green fluorescent protein, and the biosensor protein produced by the method |
| 04/10/2003 | US20030068673 Atherosclerosis susceptibility gene locus 1 (Athsq1) and atherosclerosis susceptibility gene locus 2 (Athsq2) |
| 04/10/2003 | US20030068672 Nucleotide sequences coding polypeptide for use in the treatment of psychological, respiratory, cardiovascular and pain disorders |
| 04/10/2003 | US20030068671 Polypeptide for use in the prevention, treatment and diagnosis of infections, eating, nervous system, blood, immunological and diabetic disorders |
| 04/10/2003 | US20030068670 Generation of bioactive peptides; obtain protein sample, incubate with acid, expose to pepsin, remove solids, remove lipids, recover bioactive peptide |
| 04/10/2003 | US20030068661 Inhibition of BEHAB cleavage and primary central nervous system (CNS) tumors |
| 04/10/2003 | US20030068659 ICAM-4 materials and methods |
| 04/10/2003 | US20030068651 Detection of active sites in proteins; obtain proteins, expose to spectrum analysis, monitor patterns, compare to controls, monitor binding activity, evaluate binding activity |
| 04/10/2003 | US20030068650 Detection of protein binding compounds; obtain protein, expose to spectrum analysis, incubate with binding compound, subject to spectrum analysis, monitor adjustment, compare to control, adjustment in spectrum indicates bound protein |
| 04/10/2003 | US20030068648 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/10/2003 | US20030068647 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of nervous system and cancer disorders |
| 04/10/2003 | US20030068641 Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof |
| 04/10/2003 | US20030068640 Diagnosing vision defects in mammals; obtain tissue sample, extract nucleotide sequences, detect mutaion in tigr allele, presence of mutation indicates vision defects |
| 04/10/2003 | US20030068630 Protein complex for use in the treatment of non-insulin dependent diabetes mellitus and nervous system disorders |
| 04/10/2003 | US20030068628 Nucleotide sequences coding for variable regions of beta chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses |
| 04/10/2003 | US20030068627 Nucleic acids, proteins, and antibodies |
| 04/10/2003 | US20030068624 Compositions and methods relating to lung specific genes and proteins |
| 04/10/2003 | US20030068623 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/10/2003 | US20030068619 TNF receptor 2 related protein variant |
| 04/10/2003 | US20030068618 Novel proteins and nucleic acids encoding same |
| 04/10/2003 | US20030068363 Complexes consisting of an isolated major histocompatibility complex component and an autoantigenic peptide associated with the antigen binding site of the component; useful in treating autoimmune disease |
| 04/10/2003 | US20030068335 Polynucleotide compositions toxic to diabrotica insects, and methods of use |
| 04/10/2003 | US20030068333 Cocktail of >/= 4 different plasmid DNAs encoding corresponding respiratory syncytial virus antigens, coacervated with chitosan to formulate nanospheres |
| 04/10/2003 | US20030068332 Replication-competent recombinant virus and methods of use thereof |
| 04/10/2003 | US20030068327 Compositions and methods for the diagnosis and threatment of herpes simplex virus infection |
| 04/10/2003 | US20030068325 A peptide immunogen of about 20 to 100 amino acids long comprising: a helper T cell (Th) epitope, an N-terminal fragment of A beta 1-42 peptide, consisting from 10-28 amino acid residues |
| 04/10/2003 | US20030068323 Hybrid compositions for intracellular targeting |
| 04/10/2003 | US20030068316 An antibody that interacts preferentially with soluble, non-fibrillar oligomeric assemblies of amyloid beta derived diffusible ligands; applied for diagnosis, prevention and treatment of neurodegenerative diseases |
| 04/10/2003 | US20030068312 Novel human dickkopf-related protein and nucleic acid molecules and uses therefor |
| 04/10/2003 | US20030068311 Transmembrane protein differentially expressed in cancer |
| 04/10/2003 | US20030068310 Alleviation of the memory deficits and memory components of psychiatric dysfunctions by altering atypical PKM activity |
| 04/10/2003 | US20030068301 Nucleic acid molecules, including antisense and enzymatic nucleic acid molecules which modulate synthesis, expression and/or stability of an RNA encoding one or more protein components of Hepatitis B virus |
| 04/10/2003 | US20030068300 Crystalline IL-6 and models of the molecular structure of IL-6 |
| 04/10/2003 | US20030067478 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/10/2003 | US20030067396 Electronic vehicle toll collection system and method |
| 04/10/2003 | CA2776522A1 Development of a preventive vaccine for filovirus infection in primates |
| 04/10/2003 | CA2776391A1 Development of a preventive vaccine for filovirus infection in primates |
| 04/10/2003 | CA2776272A1 Development of a preventive vaccine for filovirus infection in primates |
| 04/10/2003 | CA2768340A1 Copolymers for suppression of autoimmune diseases, and methods of use |
| 04/10/2003 | CA2466020A1 Rsv gene expression vaccine |
| 04/10/2003 | CA2464690A1 Muteins of apolipoprotein d |
| 04/10/2003 | CA2463404A1 Fragements of heat shock proteins and their use |
| 04/10/2003 | CA2462796A1 Gene regulatory peptides |
| 04/10/2003 | CA2462795A1 Secreted proteins |
| 04/10/2003 | CA2462790A1 Ul16 binding protein 4 |
| 04/10/2003 | CA2462644A1 Human and murine cytokine polypeptides |
| 04/10/2003 | CA2462638A1 Methods and compositions for modulating apoptosis |
| 04/10/2003 | CA2462632A1 Introduction of the wlds gene for prevention of axonal degeneration in neurological diseases |
| 04/10/2003 | CA2462596A1 Storage-stable human fibrinogen solutions |
| 04/10/2003 | CA2462443A1 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
| 04/10/2003 | CA2462424A1 A novel g protein-coupled receptor, gave 10 |
| 04/10/2003 | CA2462259A1 Mammalian cell-infecting virus vector encoding epitope-bound .beta.2m and utilization thereof |
| 04/10/2003 | CA2462162A1 Identification of new cd8 epitopes from hiv-1 proteins with therapeuticaal and vaccinal properties against hiv infections |
| 04/10/2003 | CA2462143A1 Genetic sequence related to bone diseases |
| 04/10/2003 | CA2462140A1 Ferroportin-1 mutant |
| 04/10/2003 | CA2462077A1 Fluorescent proteins |
| 04/10/2003 | CA2462076A1 Esr2 - a plant gene that can promote plant regeneration and transformation |
| 04/10/2003 | CA2462017A1 Non-human animal model for analysis of the origin and therapy of organ fibrosis |
| 04/10/2003 | CA2461998A1 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 04/10/2003 | CA2461713A1 Sodium-independent transporter transporting small-sized neutral amino acid, gene thereof and method of analyzing transporter function by constructing fused proteins enabling the specification of the function |
| 04/10/2003 | CA2461606A1 Nonhuman mammal model of autoimmune disease having ox40l gene transferred thereinto |
| 04/10/2003 | CA2461292A1 Apo-2 ligand variants and uses thereof |
| 04/10/2003 | CA2461280A1 Novel nucleic acids and polypeptides |
| 04/10/2003 | CA2461267A1 Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 04/10/2003 | CA2461254A1 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same |
| 04/10/2003 | CA2461099A1 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 04/10/2003 | CA2460916A1 Methods and compositions for modulating interleukin-21 receptor activity |
| 04/10/2003 | CA2460770A1 Diagnosing, treating, and preventing cancer using cables |
| 04/10/2003 | CA2460396A1 Isolated grp94 ligand binding domain polypeptide and nucleic acid encoding same, crystalline form of same, and screening methods employing same |
| 04/10/2003 | CA2460261A1 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer |
| 04/10/2003 | CA2460257A1 Methods for diagnosing and treating heart disease |
| 04/10/2003 | CA2458818A1 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 04/10/2003 | CA2455389A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/10/2003 | CA2455225A1 Novel proteins and nucleic acids encoding same |
| 04/10/2003 | CA2438330A1 A method for the early detection of cancer |
| 04/09/2003 | EP1300682A1 Methods for finding modulators of DYRK3 and DYRK2 |
| 04/09/2003 | EP1300467A1 Novel polypeptide and dna thereof |
| 04/09/2003 | EP1300464A1 Fungal cell wall synthesis gene |
| 04/09/2003 | EP1300463A1 Isolated nucleic acid molecules encoding SSX family members and uses thereof |